NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS) Status COMPLETED Phase PHASE3
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM) Status COMPLETED Phase PHASE3
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00409682 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE3
NCT00409617 Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease Status COMPLETED Phase PHASE3
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon Status COMPLETED Phase PHASE3
NCT00348153 Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Status UNKNOWN Phase PHASE2/PHASE3
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE) Status COMPLETED Phase PHASE3
NCT00298272 Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT00291915 Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis Status UNKNOWN Phase PHASE4
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) Status COMPLETED Phase PHASE3
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate Status COMPLETED Phase PHASE3